Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05509270 · ClinicalTrials.gov registry record · NA

Efficacy of Communication Modalities for Promoting Flu Shots

A NA study of Health Behavior and Risk Reduction, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
43,225
Enrollment target
1
Study location

NCT05509270 is a NA study of Health Behavior and Risk Reduction that has completed, run by Geisinger Clinic. The registered enrollment target is 43,225 participants, above the 1,521-participant average among 65 other Health Behavior trials with a reported enrollment target (2742% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05509270, a NA study of Health Behavior and Risk Reduction, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
43,225 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test which modalities (mailed letter, short message service \[SMS\] text, or patient portal messages) are most effective for encouraging flu shots in high-risk patients.

Conditions Studied

Health Behavior Risk Reduction Health Promotion Influenza Vaccination

Interventions

  • BEHAVIORAL Letter
  • BEHAVIORAL SMS
  • BEHAVIORAL Patient portal

Study Locations (1)

Pennsylvania

  • Geisinger - Danville

Trial Details

FieldValue
Enrollment Target 43,225 participants
Start Date 2022-09-06
Est. Completion 2022-10-04
Phase NA

Sponsor

Geisinger Clinic

107 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05509270

The ClinicalTrials.gov registry entry for NCT05509270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43,225 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,521-participant average among 65 other Health Behavior trials with a reported enrollment target (2742% higher). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Health Behavior appearing as the primary indexed condition, and to 3 interventions - of which Letter is the first listed.

NCT05509270 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05509270 about?

NCT05509270 is a clinical study titled "Efficacy of Communication Modalities for Promoting Flu Shots". The purpose of this study is to test which modalities (mailed letter, short message service \[SMS\] text, or patient portal messages) are most effective for encouraging flu shots in high-risk patients.

What is the current status of trial NCT05509270?

This trial is currently completed. It is a NA study. The enrollment target is 43,225 participants. The study started on 2022-09-06. Estimated completion is 2022-10-04.

What conditions does trial NCT05509270 study?

This clinical trial studies the following conditions: Health Behavior, Risk Reduction, Health Promotion, Influenza Vaccination.

What interventions are being tested in trial NCT05509270?

The interventions under investigation include: Letter (BEHAVIORAL), SMS (BEHAVIORAL), Patient portal (BEHAVIORAL).

Who is sponsoring clinical trial NCT05509270?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05509270 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Health Behavior

All registered trials for this condition

Risk Reduction

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.